STW-264

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSTW-264
Drug Alias NameSTW264STW-264
ClassificationBiologics
Mechanisms of ActionT cell immunoglobulin and ITIM domains inhibitors
TargetsT cell immunoglobulin and ITIM domains
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Stainwei Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Stainwei Biotech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A